In late December, CMS released a new online dashboard to look at Medicare prescription drugs for both Part B and Part D. These categories include drugs with high spending on a per user basis, high spending for the program overall, and those with high unit cost increases in recent years. CMS said it intends to update this list on a regular basis and release a similar list for Medicaid next year.
Not all drug expenditures will be included on the dashboard. For all drugs included on the list, the dashboard displays relevant spending, utilization, and trend data and also includes consumer-friendly information on the drug product descriptions, manufacturers, and clinical indications. CMS is prohibited from publicly disclosing information on manufacturer rebates, so the data used to select Part D drugs do not reflect any manufacturers’ rebates or other price concessions.